$14.070
+0.594 (+4.22%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CBIO Prediction & Forecast by Similar Chart Analysis
Alphio's CBIO stock price prediction model matches the current Crescent Biopharma, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.96 (-0.79%). The 1-week path is $13.76 (-2.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Crescent Biopharma, Inc. Stock?
Crescent Biopharma Inc is a good buy right now due to its recent positive developments and potential for growth. The stock is currently priced at $12.82, significantly lower than the analyst price target of $36, indicating a potential upside of over 180%. Additionally, the company has a strong gross margin of 100% projected for Q4 2025, which suggests high profitability on future revenue. However, investors should be cautious of the net loss of $24.8 million reported in Q2 2026, which reflects ongoing financial challenges.
CBIO stock price ended at $14.07 on Thursday, after rising +4.22%
Crescent Biopharma, Inc. (CBIO) last closed at $14.0699997, gaining +4.22%. These facts feed the 1-day and 1-week CBIO price prediction above.
Forecast Drivers
Crescent Biopharma, Inc. (CBIO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CBIO, ranked by similarity.
Seasonality analysis for CBIO
Historically the probability of a positive October return for CBIO is 32.35%. February offers the highest probability of a positive month at 79.31%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CBIO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $11.47 | $13.05 | $13.33 | -7.23% |
| Nov 2026 | $9.74 | $11.91 | $13.71 | -15.38% |
| Dec 2026 | $12.31 | $13.20 | $15.22 | -6.21% |
In 2026, Crescent Biopharma, Inc. (CBIO) is projected to range from $9.74 to $15.22.
Crescent Biopharma, Inc. 2026 monthly forecast
In Oct 2026, Crescent Biopharma, Inc. is projected to average $13.05, with a low of $11.47 and high of $13.33.
In Nov 2026, Crescent Biopharma, Inc. is projected to average $11.91, with a low of $9.74 and high of $13.71.
In Dec 2026, Crescent Biopharma, Inc. is projected to average $13.20, with a low of $12.31 and high of $15.22.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.